Pallas Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.57M Buy
28,518
+2,785
+11% +$153K 0.06% 231
2025
Q1
$1.82M Buy
25,733
+22,527
+703% +$1.59M 0.08% 196
2024
Q4
$211K Sell
3,206
-3,938
-55% -$259K 0.01% 545
2024
Q3
$503K Buy
+7,144
New +$503K 0.02% 356